Astrazeneca Share News (AZN)

UPDATE 6-AbbVie cools on $55 bln Shire deal after U.S. tax changes

* AbbVie says it is reconsidering backing for deal * Shire shares down 23 percent * AbbVie board to meet on Oct. 20 * Deal was partly motivated by tax benefits * Shire urges AbbVie to stick to original plan (Adds analyst comment, Shire waiving 3-day notification, adds NE

UPDATE 6-AbbVie cools on $55 bln Shire deal after U.S. tax changes

* AbbVie says it is reconsidering backing for deal * Shire shares down 23 percent * AbbVie board to meet on Oct. 20 * Deal was partly motivated by tax benefits * Shire urges AbbVie to stick to original plan (Adds analyst comment, Shire waiving 3-day notification) B

3rd UPDATE: Shire Urges AbbVie To Proceed With Takeover, Notes Big Break Fee

UPDATE 5-AbbVie cools on $55 bln Shire deal after U.S. tax changes

* AbbVie says it is reconsidering backing for deal * Shire shares down 23 percent * AbbVie board to meet on Oct. 20 * Deal was partly motivated by tax benefits * Shire urges AbbVie to stick to original plan (Adds Breakingviews link) By Paul Sandle and Sarah Young</

UPDATE 4-AbbVie cools on $55 bln Shire deal after U.S. tax changes

* AbbVie says it is reconsidering backing for deal * Shire shares down 23 percent * AbbVie board to meet on Oct. 20 * Deal was partly motivated by tax benefits * Shire urges AbbVie to stick to original plan (Adds analyst comments, background on companies, updates shares)

MARKET COMMENT: FTSE Suffers Worst Fall Of 2014 As Fear Grips Market

Hedge funds bleed as AbbVie reconsiders Shire bid

* Hedge funds' hit as Shire slumps * AbbVie reconsiders its bid * John Paulson and Paul Singer have stakes in Shire By Sudip Kar-Gupta and Nishant Kumar LONDON, Oct 15 (Reuters) - Some of the world's best known hedge funds lost hundreds of millions of dollars in the value

BUZZ-Shire Plc: Back to where it all started as M&A premium vanishes

(Updated) ** Shire shares slammed after AbbVie says it is reconsidering inversion deal ** Sharpest one-day drop for Shire shares since February 2002, wipes off $14 billion in its market value and takes stock back where it was when news of AbbVie deal first broke in June ** Even

UPDATE 3-AbbVie cools on $55 bln Shire deal after U.S. tax changes

* AbbVie says it is reconsidering backing for deal * Shire shares down 27 percent * AbbVie board to meet on Oct. 20 * Deal was partly motivated by tax benefits * Shire urges AbbVie to stick to original plan (Adds further details) By Paul Sandle and Sarah Young <

UK WINNERS & LOSERS: Takeover News Sinks Shire But Drives CSR Higher

2nd UPDATE: Shire Urges AbbVie To Proceed With Takeover, Notes Big Break Fee

UPDATE 2-AbbVie cools on $55 bln Shire deal after U.S. tax changes

* AbbVie says reconsidering backing for deal * Shire shares down 27 percent * AbbVie board to meet on Oct. 20 * Deal was partly motivated by tax benefits * Shire urges AbbVie to stick to original plan (Adds background, reaction) By Paul Sandle and Sarah Young <p

BUZZ-Shire: back to where it all started as M&A premium vanishes

** Shire shares slammed after AbbVie says it is reconsidering deal. ** Sharpest one-day drop for Shire shares since Feb 2002 wipes off $14 bln in its market value and takes stock right back where it was when news of AbbVie deal first broke in June. ** Even after drop Shire is second-b

AbbVie To Reconsider Shareholder Recommendation On Inversion Deal For Shire

UPDATE 2-Ex-Merck analyst faces insider trading charges on merger tips

(Adds comment from Merck spokeswoman in paragraph eight, updates court appearance status in paragraph six) By Emily Flitter NEW YORK, Oct 14 (Reuters) - Federal prosecutors in New York charged a former Merck & Co Inc employee with conspiracy to commit fraud for tipping a contact about